Journal of Microbiology

The Microbiological Society of Korea (한국미생물학회)
권호 표지

Concentration of CCCP Should Be Optimized to Detect the Efflux System in Quinolone-Susceptible Escherichia coli

  • Hyengun Cho (Department of Biology, Seoul Women´s University) ;
  • Yoojung Oh (Department of Biology, Seoul Women´s University) ;
  • Park, Seohyung (Department of Biology, Seoul Women´s University) ;
  • Lee, Yeonhee (Department of Biology, Seoul Women´s University)
  • Published : 2001.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Unlike eukaryotic efflux pumps energized by ATPase bacterial efflux pumps are energized by the proton motive force. That is the reason why CCCP, an inhibitor of proton motive forcer is widely used to study the bacterial efflux pump. In many cases, efflux systems have been observed only in quinolone-resistant bacteria. Most of the quinolone-susceptible strains have been found to maintain little efflux pump. However some susceptible bacteria skewed the increased intracellular quinolone concentration only at a low concentration (0.01 or 0.1 mM) but net at a high concentration (1 mM) of CCCP. If bacterial cells were killed at high concentrations of CCCP and lost the integrity of their membranes, the intracellular quinolone would leak out from cells with no efflux system. The efflux pump system in the quinolone-susceptible strains could net be detected at the same concentration used for resistant bacteria. To test this hypothesist the intracellular quinolone concentration in the quinolone-susceptible and -resistant strains of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus was assayed at various concentrations of CCCP. Since the effect of CCCP is very rapid, the survival of bacteria was observed by assaying the DNA synthesis in 5 min. In the case of E. coli, but not P. aeruginosa or S. aureus, the quinolone susceptible strain was more susceptible to CCCP than the quinolone resistant ones, especially when the incubation with CCCP was extended. Decrease of the intracellular quinolone concentration resulted in a false result-no or weak efflux system in the quinolone susceptible strains. Results suggested that the concentration of CCCP should be optimized in order to detect the efflux system in the quinolone susceptible strains of E. coli.

Keywords

References

  1. Mol. Microbiol. v.16 Resistance to mecillinam produced by the co-operative action of mutations affecting lipopolysaccharide, spoT, and cya or crp genes of Salmonella typhimurium Anton D.N.
  2. Antibiot. Chemother. v.17 Mode of action of nalidixic acid Bauernfeind A.
  3. J. Mol. Biol. v.258 DNA gyrase and topoisomerase Ⅳ on the bacterial chromosome: quinolone-induced DNA cleavage Chen C.R.;M. Malik;M. Synder;K. Drlica
  4. Agents Chemother v.32 Endogenous active efflux of norfloxacin in susceptible Escherichia coli Cohen S.P.;E.C. Hooper;J.S. Wolfson;L.M. McMurry;S.B. Levy
  5. Agent Chemother. v.42 Effects of mutations in GrlA of topoisomerase Ⅳ from Staphylococcus aureus on quinolone and coumarin activity Fournier B.;D.C. Hooper
  6. Biochem. Biophys. Res. Comm. v.242 Involvement of an efflux system in high-level fluoroquinolone resistance of Shigella dysenteriae Ghosh A.S.;J. Ahamed;K.K. Chauhan;M. Kundu
  7. Antimicrob. Agents Chemother. v.40 Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli Heisig P.
  8. Drugs v.49 no.suppl.2 Quinolone mode of action Hooper D.C.
  9. Microb. Drub Resist. v.4 Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa Jalal S.;B. Wretlind
  10. Antimicrob. Agents Chemother. v.43 Activities of newer fluoroquinolones against Streptococcus pnemoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci Jorgensen J.H.;L.M. Weigel;M.J. Ferraro;J.M. Swenson;F.C. Tenover
  11. FEBS Lett. v.193 Energetics of tetracycline efflux system encoded by Tn10 in Escherichia coli Kaneko M.;A. Yamaguchi;T. Sawai
  12. Arch. Pharm. Res. v.19 Norfloxacin resistance mechanism of E. coli 11 and E. coli 101-clinical isolates of Escherichia coli in Korea Kim K.;S. Lee;Y. Lee
  13. Agents Chemother. v.41 Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa Kohler T.;M. Michea-Hamzehpour;P. Plesiat;A.L. Kahr;J.C. Pechere
  14. Arch. Pharm. Res. v.21 Ofloxacin resistance mechanism in PA150 and PA300-clinical isolates of Pseudomonas aeruginosa in Korea Lee S.;Y. Lee
  15. Chemotherapy v.38 Lipopolysaccharide alterations responsible for combined quinolone and beta-lactam resistance in Pseudomonas aeruginosa Leying H.J.;K.H. Bucher;W. Cullmann;R.L. Then
  16. Curr. Opin. Microbiol. v.1 Bacterial solute uptake and efflux systems Lolkema J.S.;B. Poolman;W.N. Konings
  17. Microbiol. v.144 Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes Mallea M.;J. Chevalier;C. Bornet;A. Eyraud;A. Davin-Regli;C. Bollet;J.M. Pages
  18. Antimicrob. Agents Chemother. v.44 Assignment of the substrate-selective subunits of the MexEF-OprN multidrug efflux ump of Pseudomonas aeruginosa Maseda H.;H. Yoneyama;T. Nakae
  19. Antimicrob. Agents Chemother. v.43 Efflux pump-mediated quinolone resistance in Staphylococcus aureus strains wild type for gyrA, gyrB, grlA, and norA Munoz-Bellido J.L.;A. Manzanares;M. Andrea;G. Zufiaurre;G. Ortiz;S. Hernendez;G. Rodriguez
  20. Microbios v.81 Lethal effect of carbonyl cyanide m-chlorophenylhydrazone on Escherichia coli and a halotolerant Brevibacterium species Nagata S.
  21. Science v.264 Prevention of drug access to bacterial targets: permeability barriers and active efflux Nikaido H.
  22. Curr. Opin. Microbiol. v.1 Multidrug antibiotic resistance and efflux Nikaido H.
  23. Antimicrob. Agents Chemother. v.40 Quinolone resistance mutations in topoisomerase Ⅳ: relationship to the flqA locus and genetic evidence that topoisomerase Ⅳ is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus Ng E.Y.;M. Trucksis;D.C. Hooper
  24. J. Antimicrob. Chemother. v.41 Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli Oethinger M.;W.V. Kern;J.D. Goldman;S.B. Levy
  25. Antimicrob. Agents Chemother. v.42 DNA gyrase and topoisomerase Ⅳ are dual targets of clinafloxacin action in Streptococcus pneumoniae Pan X.S.;L.M. Fisher
  26. Mol. Cells v.6 Norfloxacin Resistance mechanism of Escherichia coli 59-a clinical isolate in Korea Park S.;S. Lee;Y. Lee
  27. Microbiol. Rev. v.60 Proton-dependent multidrug efflux systems Paulsen I.T.;M.H. Brown;R.A. Skurray
  28. J. Antimicrob. Chemother. v.26 Outer membrane proteins responsible for the penetration of beta-lactams and quinolones in Pseudomonas aeruginosa Yamano Y.;T. Nishikawa;Y. Komatsu